Cheilbio financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Rev. Revenue
₩14.34B ₩13.18B ₩11.97B ₩12.28B ₩12.33B ₩11.34B ₩16.66B ₩25.60B ₩36.87B ₩38.37B ₩39.53B ₩34.98B ₩35.82B ₩27.99B ₩27.81B ₩22.99B ₩19.00B ₩16.91B ₩15.35B ₩0.00M
GM % Gross Margin %
18.14% 13.54% 18.51% 12.96% 8.40% 20.47% 14.97% 12.88% 9.70% 8.81% 10.92% 16.92% 18.00% 21.88% 20.16% 21.00% 19.72% 12.79% 15.53% 0.00%
OM Operating Margin
-0.24% -2.73% -0.46% -6.29% -8.80% 3.35% 2.32% 1.26% 2.38% 0.66% 2.58% 2.97% 2.30% 3.96% 5.05% 2.26% -2.57% -10.21% -9.68% 0.00%
EPS Earnings Per Share
₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
8m 9.6m 9.6m 9.6m 9.6m 9.6m 9.6m 9.6m 9.6m 9.6m 9.6m 15m 15m 15m 15m 15m 30m 29.13m 27.01m 0m
OCF Operating Cash Flow
₩647.40M ₩308.89M ₩1.41B ₩-189.69M ₩-61.48M ₩1.26B ₩140.35M ₩-1583.06M ₩297.51M ₩1.17B ₩180.25M ₩-119.83M ₩2.20B ₩3.24B ₩-3560.14M ₩5.02B ₩-3275.23M ₩-103.52M ₩7.73B ₩0.00M
FCF Free Cash Flow
₩-285.46M ₩-278.96M ₩245.77M ₩-654.97M ₩-231.25M ₩985.67M ₩-110.41M ₩-1871.28M ₩-708.64M ₩956.87M ₩-986.81M ₩-444.99M ₩201.03M ₩3.11B ₩-3740.40M ₩5.00B ₩-3289.14M ₩-168.49M ₩7.72B ₩0.00M
FCFS Free Cash Flow Per Share
₩-35.68 ₩-31.29 ₩9.69 ₩-66.92 ₩-12.54 ₩102.67 ₩-11.60 ₩-195.38 ₩-73.87 ₩96.97 ₩-103.24 ₩-43.59 ₩13.48 ₩216.46 ₩-273.29 ₩373.48 ₩-115.83 ₩-5.91 ₩281.07 ₩0.00